ONO-9054 ophthalmic solution

ONO-9054 · Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONO-9054 ophthalmic solution, covering 2016-02-25 to 2016-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) [Phase 2]

See pricing